Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of SJP002 ophthalmic solution for dry eye syndromes has completed

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• SJP002

Snippet

Sponsor: Samjin Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED